Kancera AB (publ) (KAN) - Total Liabilities

Latest as of June 2025: Skr3.58 Million SEK ≈ $385.05K USD

Based on the latest financial reports, Kancera AB (publ) (KAN) has total liabilities worth Skr3.58 Million SEK (≈ $385.05K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kancera AB (publ) - Total Liabilities Trend (2010–2024)

This chart illustrates how Kancera AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See Kancera AB (publ) current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Kancera AB (publ) Competitors by Total Liabilities

The table below lists competitors of Kancera AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
GRUPUL INDUSTRIAL ELECTROCONTACT S.A. RO:ECT	Romania	RON932.70K
Astron Paper & Board Mill Limited NSE:ASTRON	India	Rs1.26 Billion
Tianci International, Inc. Common Stock NASDAQ:CIIT	USA	$101.34K
ModuLink Inc. NASDAQ:MDLK	USA	$835.06K
Biodexa Pharmaceticals NASDAQ:BDRX	USA	$6.76 Million
EF EnergyFunders Ventures Inc V:EFV	Canada	CA$9.35 Million
Fitell Corporation Ordinary Shares NASDAQ:FTEL	USA	$2.21 Million
Epwin Group PLC LSE:EPWN	UK	GBX193.00 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Kancera AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see KAN company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kancera AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kancera AB (publ) (2010–2024)

The table below shows the annual total liabilities of Kancera AB (publ) from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr4.61 Million ≈ $496.22K	-74.35%
2023-12-31	Skr17.98 Million ≈ $1.93 Million	+30.03%
2022-12-31	Skr13.83 Million ≈ $1.49 Million	+27.19%
2021-12-31	Skr10.87 Million ≈ $1.17 Million	+0.47%
2020-12-31	Skr10.82 Million ≈ $1.16 Million	-59.83%
2019-12-31	Skr26.93 Million ≈ $2.90 Million	+121.21%
2018-12-31	Skr12.18 Million ≈ $1.31 Million	-2.70%
2017-12-31	Skr12.51 Million ≈ $1.35 Million	-7.35%
2016-12-31	Skr13.51 Million ≈ $1.45 Million	+146.21%
2015-12-31	Skr5.49 Million ≈ $590.38K	-39.92%
2014-12-31	Skr9.13 Million ≈ $982.64K	+36.43%
2013-12-31	Skr6.69 Million ≈ $720.27K	-49.18%
2012-12-31	Skr13.17 Million ≈ $1.42 Million	-4.82%
2011-12-31	Skr13.84 Million ≈ $1.49 Million	+370.04%
2010-12-31	Skr2.94 Million ≈ $316.82K	--

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#29969 Global

#694 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr1.86

All Time High

Skr38.15